Navigation Links
Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
Date:9/15/2008

VEENENDAAL, Netherlands, September 15 /PRNewswire/ --

- Oncentra(R) RT Viewer* Officially to Launch at ESTRO 2008 in Gothenburg, Sweden, September 14-18 and ASTRO 2008, Boston, USA, September 21-24

Nucletron, a knowledge-based leader in radiation oncology today announced the market release of Oncentra RT Viewer. This unique innovation in treatment planning solutions from Nucletron allows clinicians to review radiotherapy plans that are generated with a wide variety of DICOM-compliant treatment planning systems, in a Windows PC-based environment.

Oncentra RT Viewer makes it possible to review and share treatment planning data, such as DICOM RT Images, RT Structure sets, RT Plans and RT doses, on any computer, making it a powerful tool for clinical consulting and peer-to-peer reviewing. Oncentra RT Viewer therefore is a great alternative for reviewing and sharing treatment planning data with paper hardcopies. This solution allows the digital sharing of plans on the hospital's network, or on any other electronic sharing device.

"Oncentra RT Viewer makes data distribution very easy and efficient. It allows reviewing treatment plans and sharing knowledge with colleagues, anywhere and anytime, ultimately resulting in improving patient care," says Paul van den Biggelaar, Director of New Product Development at Nucletron.

Oncentra RT Viewer will be available for demonstration at ESTRO, Nucletron Booth B02:50 from September 14-18, as well as ASTRO, Nucletron Booth 1602 from September 21-24.

* Oncentra RT Viewer is not currently available for sale in North America, pending regulatory clearance.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit http://www.nucletron.com.


'/>"/>
SOURCE Nucletron B V
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
2. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
3. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
4. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
5. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
8. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
9. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
10. Chromos announces shareholder approval of Arrangement
11. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):